Genmab A/s Earnings

Genmab A/s’s revenue jumped 16.78% since last year same period to $5540Mn in the Q3 2024. On a quarterly growth basis, Genmab A/s has generated 2.55% jump in its revenue since last 3-months.

Genmab A/s’s net profit fell -40.54% since last year same period to $1266Mn in the Q3 2024. On a quarterly growth basis, Genmab A/s has generated -10.09% fall in its net profits since last 3-months.

Genmab A/s’s net profit margin fell -49.08% since last year same period to 22.85% in the Q3 2024. On a quarterly growth basis, Genmab A/s has generated -12.32% fall in its net profit margins since last 3-months.

Genmab A/s’s earning per share (EPS) estimates for the current quarter stand at 0.35 - a 6.06% jump from last quarter’s estimates.

Genmab A/s’s earning per share (EPS) estimates for the current year stand at 0.35.

Genmab A/s’s earning per share (EPS) fell -38.3% since last year same period to 0.29 in the Q3 2024. This indicates that the Genmab A/s has generated -38.3% annual rate of fall in its earning per share (EPS) in the last 4 quarters.